​

Immix Biopharma Ownership | Who Owns Immix Biopharma?


OverviewForecastFinancialsChart

Immix Biopharma Ownership Summary


Immix Biopharma is owned by 103.30% institutional investors, 14.62% insiders. Janus henderson group is the largest institutional shareholder, holding 12.54% of IMMX shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 5.44% of its assets in Immix Biopharma shares.

IMMX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmix Biopharma103.30%14.62%-17.92%
SectorHealthcare Stocks 128.69%12.02%-40.72%
IndustryBiotech Stocks 180.58%11.62%-92.20%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group4.80M12.54%$43.70M
Saturn v capital management3.69M9.65%$33.65M
Eventide asset management5.19M8.13%$53.97M
Blackrock funding, inc. /de4.54M7.12%$47.24M
State street3.30M5.18%$34.38M
Vanguard capital management3.00M4.71%$31.24M
Millennium management1.75M4.57%$15.94M
Vanguard group1.10M3.43%$5.73M
Logos global management lp1.23M3.20%$11.16M
Marshall wace, llp1.85M2.91%$19.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Monashee investment management450.00K14.02%$4.68M
Saturn v capital management3.69M6.09%$33.65M
Velan capital investment management lp740.00K4.22%$6.74M
Kvp capital advisors, lp230.42K1.93%$2.40M
Imprint wealth31.25K1.30%$284.67K
Blue owl capital lp602.05K1.14%$6.26M
Bleichroeder lp1.00M1.02%$10.40M
Eventide asset management5.19M0.76%$53.97M
Great point partners350.00K0.73%$3.19M
Logos global management lp1.23M0.56%$11.16M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de4.54M0.00%1.55M
Eventide asset management5.19M0.76%1.30M
Janus henderson group4.80M0.02%880.43K
Abrdn818.67K0.01%818.67K
Franklin resources1.79M0.00%818.18K

Top Sellers

HolderShares% AssetsChange
Ubs group186.50K0.00%-1.76M
Adage capital partners gp---1.50M
Aigh capital management---1.12M
Cable car capital---779.36K
Ameriprise financial---452.15K

New Positions

HolderShares% AssetsChangeValue
Abrdn818.67K0.01%818.67K$8.52M
Monashee investment management450.00K14.02%450.00K$4.68M
Price t rowe associates inc /md/415.00K0.00%415.00K$3.78M
Great point partners350.00K0.73%350.00K$3.19M
Picton mahoney asset management333.25K0.02%333.25K$3.47M

Sold Out

HolderChange
Northwestern mutual wealth management-11.00
Fortitude family office-53.00
Raymond james financial-525.00
Group one trading-879.00
Tortoise investment management-1.30K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202614426.32%65,875,40116.91%1031.32%10526.51%2283.33%
Jun 30, 202611444.30%56,354,585108.13%883.70%8260.78%13-7.14%
Mar 31, 202625-63.77%3,096,764-87.30%80.14%18-68.42%3-57.14%
Dec 31, 202531-3.13%9,543,371243.79%2934.87%2728.57%433.33%
Sep 30, 20252618.18%1,748,673-18.18%511.48%1677.78%3-25.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I3.89M5.44%1.34M
Janus Henderson Hrzn Biotec E2 USD1.95M2.74%495.89K
Vanguard MStar Total Stk Mkt Idx Invest2.24M2.70%456.50K
State Street® SPDR® S&P® Biotech ETF2.21M2.66%57.74K
Vanguard Morn Total Stk Mkt Idx Investor1.78M2.50%494.90K
Vanguard Total Stock Mkt Idx Inv1.78M2.50%494.90K
iShares Russell 2000 ETF1.50M1.81%-
Franklin Biotechnology Discv A(acc)USD1.14M1.38%530.12K
Columbia Small Cap Growth Inst986.32K1.19%236.70K
Janus Henderson Global Life Sciences D842.40K1.02%842.40K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 10, 2025Rachman Ilya M CEO and ChairmanBuy$4.98K
Dec 10, 2025Morris Gabriel S CFOBuy$5.07K
Sep 17, 2025Rachman Ilya M CEO and ChairmanBuy$5.05K
Sep 16, 2025Morris Gabriel S CFOBuy$5.12K
Jun 18, 2025Rachman Ilya M CEO and ChairmanBuy$5.00K

Insider Transactions Trends


DateBuySell
2025 Q42-
2025 Q32-
2025 Q22-
2024 Q42-
2024 Q35-

IMMX Ownership FAQ


Who Owns Immix Biopharma?

Immix Biopharma shareholders are primarily institutional investors at 103.30%, followed by 14.62% insiders and -17.92% retail investors. The average institutional ownership in Immix Biopharma's industry, Biotech Stocks , is 180.58%, which Immix Biopharma falls below.

Who owns the most shares of Immix Biopharma?

Immix Biopharma’s largest shareholders are Janus henderson group (4.8M shares, 12.54%), Saturn v capital management (3.69M shares, 9.65%), and Eventide asset management (5.19M shares, 8.13%). Together, they hold 30.32% of Immix Biopharma’s total shares outstanding.

Does Blackrock own Immix Biopharma?

BlackRock is not among the top 10 institutional shareholders of Immix Biopharma.

Who is Immix Biopharma’s biggest shareholder by percentage of total assets invested?

Monashee investment management is Immix Biopharma’s biggest shareholder by percentage of total assets invested, with 14.02% of its assets in 450K Immix Biopharma shares, valued at 4.68M$.

Who is the top mutual fund holder of Immix Biopharma shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Immix Biopharma shares, with 5.44% of its total shares outstanding invested in 3.89M Immix Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools